At the time of writing, Repligen Corp [RGEN] stock is trading at $162.67, up 7.92%. An important factor to consider is whether the stock is rising or falling in short-term value. The RGEN shares have gain 11.63% over the last week, with a monthly amount drifted -3.13%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on February 10, 2025, when TD Cowen initiated its Buy rating and assigned the stock a price target of $200. Previously, Canaccord Genuity started tracking the stock with Hold rating on December 17, 2024, and set its price target to $165. On November 14, 2024, Wolfe Research initiated with a Peer Perform rating. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $180 on August 28, 2024. Deutsche Bank upgraded its rating to a Buy and reduced its price target to $155 on June 26, 2024. In a note dated December 04, 2023, The Benchmark Company downgraded an Hold rating on this stock.
For the past year, the stock price of Repligen Corp fluctuated between $113.50 and $207.87. Currently, Wall Street analysts expect the stock to reach $220 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $162.67 at the most recent close of the market. An investor can expect a potential return of 35.24% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
According to Repligen Corp [NASDAQ:RGEN], the company’s sales were 634.44M for trailing twelve months, which represents an 0.56% jump. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 157.37 points at the first support level, and at 152.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 168.49, and for the 2nd resistance point, it is at 174.30.
Ratios To Look Out For
It is important to note that Repligen Corp [NASDAQ:RGEN] has a current ratio of 10.44. On the other hand, the Quick Ratio is 8.76, and the Cash Ratio is 7.23. Considering the valuation of this stock, the price to sales ratio is 14.37, the price to book ratio is 4.52.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Nov 21 ’24 when 24246.0 shares were sold. Executive Chairman, Anthony Hunt completed a deal on Nov 21 ’24 to buy 24246.0 shares. Meanwhile, Director Hunt Anthony sold 22191.0 shares on Sep 10 ’24.
